[Form 4] HUBSPOT, INC. Insider Trading Activity
Rhea-AI Filing Summary
Insider transactions by HubSpot director Brian Halligan on 08/19/2025: Halligan acquired 7,136 shares by exercising options with a $182.91 exercise price and acquired 1,364 shares by exercising options with a $381.74 exercise price. Both option exercises were reported as vested or exercisable and resulted in beneficial ownership of 7,136 and 1,364 shares respectively. Following these exercises, Halligan sold 8,500 shares at $449.84 each, leaving him with 522,435 shares beneficially owned.
The Form 4 notes the transactions were effected under a 10b5-1 trading plan adopted on 03/03/2025. The filing was signed by an attorney-in-fact on 08/21/2025. All amounts and prices are stated on the form.
Positive
- Transactions executed under a 10b5-1 plan adopted on 03/03/2025, indicating preplanned trading
- Option exercised was fully vested, enabling lawful exercise without additional vesting conditions
- Director retains a substantial beneficial holding of 522,435 shares after the transactions
Negative
- Director sold 8,500 shares at $449.84, representing insider liquidity which some investors may view negatively
Insights
TL;DR: Director exercised vested options and sold a portion of holdings under a 10b5-1 plan, a routine liquidity action.
The filing shows option exercises at exercise prices of $182.91 and $381.74, producing 8,500 shares acquired in total, immediately followed by a sale of 8,500 shares at $449.84. The transactions were executed pursuant to a 10b5-1 plan adopted on 03/03/2025, which indicates preplanned, rule-compliant trading rather than opportunistic timing. For investors tracking insider activity, the net effect is modest liquidity taken by the director while retaining a large beneficial stake of 522,435 shares.
TL;DR: Use of a documented 10b5-1 plan and vested option exercises align with standard governance practices.
The Form 4 explicitly states the trades were effected under a 10b5-1 trading plan adopted on 03/03/2025, which provides the affirmative defense under Rule 10b5-1(c). One disclosed stock option is fully vested per the filing. The attorney-in-fact signature on 08/21/2025 completes the required reporting. These elements reflect adherence to insider trading protocols and timely disclosure obligations.